Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022

SELL
$12.15 - $35.28 $5.2 Million - $15.1 Million
-428,378 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$30.49 - $48.49 $3.35 Million - $5.32 Million
109,751 Added 34.44%
428,378 $14.6 Million
Q3 2021

Nov 15, 2021

SELL
$41.66 - $52.52 $6.44 Million - $8.12 Million
-154,637 Reduced 32.67%
318,627 $15.4 Million
Q2 2021

Aug 10, 2021

BUY
$36.62 - $51.69 $102,975 - $145,352
2,812 Added 0.6%
473,264 $21.4 Million
Q1 2021

May 14, 2021

BUY
$41.56 - $59.88 $2.06 Million - $2.97 Million
49,645 Added 11.8%
470,452 $22.7 Million
Q4 2020

Feb 11, 2021

BUY
$36.08 - $56.47 $25,869 - $40,488
717 Added 0.17%
420,807 $22.7 Million
Q3 2020

Nov 13, 2020

BUY
$33.26 - $40.48 $11.2 Million - $13.7 Million
337,725 Added 410.03%
420,090 $15.5 Million
Q2 2020

Aug 12, 2020

SELL
$24.21 - $31.02 $2.35 Million - $3.02 Million
-97,205 Reduced 54.13%
82,365 $2.55 Million
Q1 2020

May 13, 2020

SELL
$20.5 - $34.53 $100,573 - $169,404
-4,906 Reduced 2.66%
179,570 $4.96 Million
Q4 2019

Feb 13, 2020

SELL
$18.96 - $29.84 $2.68 Million - $4.22 Million
-141,577 Reduced 43.42%
184,476 $5.4 Million
Q3 2019

Nov 13, 2019

BUY
$19.12 - $26.24 $740,689 - $1.02 Million
38,739 Added 13.48%
326,053 $6.23 Million
Q2 2019

Aug 09, 2019

SELL
$19.57 - $24.1 $30,803 - $37,933
-1,574 Reduced 0.54%
287,314 $6.3 Million
Q1 2019

May 15, 2019

SELL
$12.14 - $20.46 $267,966 - $451,613
-22,073 Reduced 7.1%
288,888 $5.91 Million
Q4 2018

Feb 14, 2019

SELL
$11.24 - $18.5 $15,061 - $24,790
-1,340 Reduced 0.43%
310,961 $3.92 Million
Q3 2018

Nov 14, 2018

BUY
$12.5 - $15.38 $3.9 Million - $4.8 Million
312,301 New
312,301 $4.79 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.93B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Nicholas Investment Partners, LP Portfolio

Follow Nicholas Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.